Resultados da busca - K. Monkhorst, MD, PhD

Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC por M. Jebbink, MD, A.J. de Langen, MD, PhD, K. Monkhorst, MD, PhD, M.C. Boelens, PhD, D. van den Broek, PhD, V. van der Noort, PhD, C.J. de Gooijer, MD, PhD, M. Mahn, MSc, A.J. van der Wekken, MD, PhD, L. Hendriks, MD, PhD, S.M.S. Hashemi, MD, PhD, M.S. Paats, MD, PhD, A.C. Dingemans, MD, PhD, E.F. Smit, MD, PhD

Obter o texto integral